(Q37080918)

English

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

scientific article published on 09 December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial (English)

1 reference

Europe PubMed Central

18 August 2017

phase II clinical trial

0 references

undifferentiated carcinoma

1 reference

based on heuristic

inferred from title

carcinoma of unknown primary

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

G Huebner

1

1 reference

Europe PubMed Central

18 August 2017

H Link

2

1 reference

Europe PubMed Central

18 August 2017

C H Kohne

3

1 reference

Europe PubMed Central

18 August 2017

M Stahl

4

1 reference

Europe PubMed Central

18 August 2017

A Kretzschmar

5

1 reference

Europe PubMed Central

18 August 2017

S Steinbach

6

1 reference

Europe PubMed Central

18 August 2017

G Folprecht

7

1 reference

Europe PubMed Central

18 August 2017

H Bernhard

8

1 reference

Europe PubMed Central

18 August 2017

S E Al-Batran

9

1 reference

Europe PubMed Central

18 August 2017

P Schoffski

10

1 reference

Europe PubMed Central

18 August 2017

C Burkart

11

1 reference

Europe PubMed Central

18 August 2017

F Kullmann

12

1 reference

Europe PubMed Central

18 August 2017

B Otremba

13

1 reference

Europe PubMed Central

18 August 2017

M Menges

14

1 reference

Europe PubMed Central

18 August 2017

M Hoffmann

15

1 reference

Europe PubMed Central

18 August 2017

U Kaiser

16

1 reference

Europe PubMed Central

18 August 2017

A Aldaoud

17

1 reference

Europe PubMed Central

18 August 2017

A Jahn

18

1 reference

Europe PubMed Central

18 August 2017

German CUP Study Group

19

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

9 December 2008

1 reference

Europe PubMed Central

18 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

18 August 2017

100

1 reference

Europe PubMed Central

18 August 2017

1

1 reference

Europe PubMed Central

18 August 2017

44-49

1 reference

Europe PubMed Central

18 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604818

0 references

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

MicroRNAs accurately identify cancer tissue origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

Cancer of unknown primary (CUP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

29 September 2017

Randomized multicenter phase II study of gemcitabine versus docetaxel as first-line therapy with second-line crossover in advanced-stage non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

3 September 2018

Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

3 September 2018

Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

3 September 2018

Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634671

3 September 2018

Molecular Profiling of a Tumor of Unknown Origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604818

21 January 2018

Epidemiology of unknown primary tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604818

21 January 2018

Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19066607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary

1 reference

https://pubmed.ncbi.nlm.nih.gov/19066607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/19066607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19066607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992

1 reference

https://pubmed.ncbi.nlm.nih.gov/19066607

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6604818

1 reference

Europe PubMed Central

18 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37080918&oldid=1682243839"